NeuroTracking software is for analysis of home-based monitoring data in Parkinson’s disease (PD). Most of 10 million PD patients suffer from varying motor symptoms daily at home, and there are no biomarkers to quantify their condition and effects of treatment. The analysis is sold to the hospitals and drug development companies as a service and the go-to-market size is 1.5 milliard €. Team has a unique, 10 years of experience for monitoring of PD